Hjem › Neurologiske sygdomme › Texas
Neurologiske sygdomme kliniske forsøg i Texas
13 studier for Neurologiske sygdomme søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Austin, Texas, Austin
- Dallas, Texas, Dallas
- Houston, Texas, Houston
- og 2 flere
RekruttererFase 2/3
Alder 18 til 70 · Alle køn · Opdateret 2. okt. 2026 · NCT07598708A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Austin
- Clinical Site, McKinney
- Clinical Site, Sugarland
RekruttererFase 2
Alder 55 til 90 · Alle køn · Opdateret 30. sep. 2026 · NCT06887192A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Gadolin Research, Beaumont
- Kerwin Medical Center, Dallas
- Houston Methodist Hospital, Houston
- og 3 flere
RekruttererFase 2
Alder 55 til 85 · Alle køn · Opdateret 22. sep. 2026 · NCT07589595Product Surveillance Registry
- Austin
- Dallas
- Fort Worth
- og 6 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 18. sep. 2026 · NCT01524276A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #049, Cypress
- Vima Site #063, Dallas
- Vima Site #058, Round Rock
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. sep. 2026 · NCT07804615Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07098806HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
RekruttererFase 1
36 Months – 22 Years · Alle køn · Opdateret 4. sep. 2026 · NCT03911388A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Austin
- Clinical Site, DeSoto
- Clinical Site, Richardson
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 1. sep. 2026 · NCT07459647Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
- University of Texas at Austin, Austin
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 17. aug. 2026 · NCT07759115Rett Syndrome Registry
- Children's Health, Dallas
- Texas Children's Hospital, Houston
RekruttererObservationsstudie
Alder 0 til 99 · Alle køn · Opdateret 30. jun. 2026 · NCT05432349INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
- University of Texas Southwestern Medical Center (UTSW), Dallas
Rekrutterer
Alder 22 og opefter · Alle køn · Opdateret 11. maj 2026 · NCT07543367Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Houston
RekruttererFase 2
Alder 50 til 85 · Alle køn · Opdateret 2. feb. 2026 · NCT07105709Epilepsy Learning Healthcare System (ELHS)
- UT Southwestern Children's Dallas, Dallas
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 30. aug. 2024 · NCT06265103Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.